IL102095A0 - Pharmaceutical compositions containing an n-methyl-d-aspartate receptor antagonist - Google Patents

Pharmaceutical compositions containing an n-methyl-d-aspartate receptor antagonist

Info

Publication number
IL102095A0
IL102095A0 IL102095A IL10209592A IL102095A0 IL 102095 A0 IL102095 A0 IL 102095A0 IL 102095 A IL102095 A IL 102095A IL 10209592 A IL10209592 A IL 10209592A IL 102095 A0 IL102095 A0 IL 102095A0
Authority
IL
Israel
Prior art keywords
methyl
pharmaceutical compositions
compositions containing
receptor antagonist
aspartate receptor
Prior art date
Application number
IL102095A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL102095A0 publication Critical patent/IL102095A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL102095A 1991-06-05 1992-06-03 Pharmaceutical compositions containing an n-methyl-d-aspartate receptor antagonist IL102095A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4118740A DE4118740A1 (de) 1991-06-05 1991-06-05 Neue kombinationspraeparate zur behandlung des morbus parkinson

Publications (1)

Publication Number Publication Date
IL102095A0 true IL102095A0 (en) 1993-01-14

Family

ID=6433409

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102095A IL102095A0 (en) 1991-06-05 1992-06-03 Pharmaceutical compositions containing an n-methyl-d-aspartate receptor antagonist

Country Status (9)

Country Link
EP (1) EP0517347A1 (xx)
JP (1) JPH05170668A (xx)
AU (1) AU1807592A (xx)
CA (1) CA2070494A1 (xx)
DE (1) DE4118740A1 (xx)
HU (1) HUT64473A (xx)
IE (1) IE921824A1 (xx)
IL (1) IL102095A0 (xx)
ZA (1) ZA924128B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
GB9305692D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
RU2176145C2 (ru) * 1995-05-26 2001-11-27 Пфайзер Инк. Синергическое лечение паркинсонизма
TW427904B (en) * 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
MX2019015120A (es) 2017-06-12 2022-07-14 Glytech Llc Composicion y metodo para el tratamiento de la depresion y psicosis en humanos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940410A1 (de) * 1989-12-04 1991-06-06 Schering Ag Neue verwendung von nmda-rezeptor-antagonisten

Also Published As

Publication number Publication date
AU1807592A (en) 1992-12-10
IE921824A1 (en) 1992-12-16
EP0517347A1 (de) 1992-12-09
CA2070494A1 (en) 1992-12-06
DE4118740A1 (de) 1992-12-10
HU9201874D0 (en) 1992-08-28
ZA924128B (en) 1993-03-25
HUT64473A (en) 1994-01-28
JPH05170668A (ja) 1993-07-09

Similar Documents

Publication Publication Date Title
IL103621A0 (en) Endothelin receptor antagonists and pharmaceutical compositions containing them
HU9303143D0 (en) Pharmaceutical compositions
HUP9901296A3 (en) Substituted piperidine derivatives as nmda receptor antagonists and pharmaceutical compositions containing them
IL99246A0 (en) Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
ZA922834B (en) Pharmaceutical compositions
IL104068A0 (en) Pharmaceutical compositions for inhalation
IL102310A0 (en) Pharmaceutical compositions comprising cyclosporins
GB9410987D0 (en) High dosage pharmaceutical compositions
IL102777A0 (en) Pharmaceutical combination formulation
HUT74746A (en) Pharmaceutical compositions containing p antagonist
GB9108080D0 (en) Pharmaceutical composition
IL102372A0 (en) Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist
GB2251617B (en) Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones
IL102095A0 (en) Pharmaceutical compositions containing an n-methyl-d-aspartate receptor antagonist
GR3022416T3 (en) Programmed-release pharmaceutical compositions
HK1004549A1 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent central nervous system stimulant or sigma receptor agonist
ZA925171B (en) Pharmaceutical compositions
GB9120672D0 (en) Pharmaceutical compositions
GB9216061D0 (en) Pharmaceutical combination formulation
GB9221212D0 (en) Pharmaceutical compositions
GB2252497B (en) Pharmaceutical composition
GB9200414D0 (en) Pharmaceutical compositions
GB9100464D0 (en) Pharmaceutical compositions
GB9123423D0 (en) Pharmaceutical compositions
GB9119048D0 (en) Pharmaceutical compositions